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Abstract 
Lannergård, J. 2006. Potentially Virulence-Related Extracellular Proteins of  
Streptococcus equi. Doctoral thesis. 
ISSN 1652-6880. ISBN 91-576-7129-X. 
 
Equine strangles, a disease of the upper respiratory tract caused by the bacterium 
Streptococcus equi subspecies equi, is one of the most commonly diagnosed and serious 
diseases in horses. However, the molecular basis of S. equi subsp. equi infection is poorly 
understood and there are no safe and effective vaccines on the market. The main objective 
of this study was to identify and characterise extracellular proteins used by S. equi subsp. 
equi to initiate infection and cause disease.  
Extracellular proteins, which can be secreted or cell surface-located, play an important 
role in the initiation of infection and in continued bacterial survival inside the host. 
Adhesins are a specific class of virulence-related proteins that are used by the bacteria to 
attach to host tissues. This study focused on a number of cell-surface anchored proteins that 
specifically adhere to collagen and fibronectin, two major extracellular matrix proteins of 
vertebrates. The binding characteristics of the fibronectin-binding protein FNEB were 
compared to two previously studied fibronectin-binding proteins, FNE and SFS. A follow-
up investigation showed that FNE and FNEB are part of a family of six similar proteins 
encoded by S. equi subsp. equi. One of the four novel proteins identified (FNEE) was 
shown to bind to fibronectin and all four to collagen. In another study, a secreted 
immunoglobulin-specific protease was characterised. This enzyme could be used by the 
bacteria to interfere with the immune response of the infected horse. A useful tool in this 
research was the public S. equi subsp. equi genome database, which can be used to identify 
homologues to virulence-related proteins of other pathogens.  
An applied objective of the present study was to identify potential components for a 
future vaccine against strangles. One of the collagen-binding proteins characterised (CNE) 
is currently being used in vaccination trials as a component of a protein subunit vaccine for 
horses.  
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α2M            α2-macroglobulin 
a a             A m i n o   a c i d s  
BLAST           Basic  Local  Alignment  Search  Tool 
cDNA             Complementary  DNA 
CNA            Collagen-binding  protein  of  S. aureus 
CNE            Collagen-binding  protein  of  S. equi subsp. equi 
C-terminal        Carboxy-terminal 
E A G             α2-macroglobulin-, albumin- and immunoglobulin G- 
binding protein of S. equi subsp. equi  
ECM            Extracellular  matrix 
Fab             Fragment  antigen  binding  of  immunoglobulin 
Fc               Fragment  crystallisable  of  immunoglobulin 
Fg             Fibrinogen 
F n              F i b r o n e c t i n  
FNE (B, C, D, E, F)        Fibronectin-binding protein of S. equi subsp. equi 
F1,  F2,  F3          Fibronectin  modules  type  1,  2  and  3 
FNZ           Fibronectin-binding  protein  of  S. equi subsp. 
zooepidemicus 
IdeE,  IdeS,  IdeZ       Immunoglobulin-degrading  enzymes  of  S. equi subsp. 
equi, S. pyogenes and S. equi subsp. 
zooepidemicus 
IgG             Immunoglobulin  G 
IS  element        Insertion  sequence  element 
k D a              K i l o D a l t o n  
L T A             L i p o t e i c h o i c   a c i d  
m R N A            M e s s e n g e r   R N A  
N M R               N u c l e a r   m a g n e t i c   r e s o n a n c e  
N-terminal        Amine-terminal 
O R F             O p e n   r e a d i n g   f r a m e  
P B S            P h o s p h a t e   b u f f e r e d   s a l i n e  
P C R            P o l y m e r a s e   c h a i n   r e a c t i o n  
PMN            Polymorphonuclear  leukocyte 
r R N A             R i b o s o m a l   R N A  
RT-PCR         Reverse-transcript  PCR 
Scl  (C-I)         Streptococcal collagen-like protein 
SDS-PAGE    Sodium dodecyl sulphate polyacrylamide gel 
     electrophoresis 
S e M            S. equi subsp. equi M-like protein 
SFS             Secreted fibronectin-binding protein of S. equi 
SS             Signal  sequence  (signal  peptide) 
S u b s p .           S u b s p e c i e s  
T A                T e i c h o i c   a c i d  
TLR           Toll-like  receptor 
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General background 
The Earth is inhabited by a massive array of bacterial species, each adapted to 
their particular ecological niche through the struggle for existence. Many bacterial 
species colonise higher organisms, and the vast majority of these have adapted to 
peacefully coexist with their hosts. In many cases this partnership can be described 
as symbiotic, for example when the bacteria provide essential nutrients and co-
factors. Other bacteria have evolved a pathogenic lifestyle, when the colonisation 
of the host results in disease. Generally speaking, a pathogen multiplies and 
persists more successfully in nature when it is transmitted between healthy and 
mobile hosts. For that reason, a successful pathogen cannot afford to cause too 
much injury during the course of infection. The more severe bacterial diseases 
observed in nature are often the result of opportunistic infections in compromised 
individuals, or ‘accidental’ infections of species that are irrelevant for the survival 
of the bacteria. However, some bacterial species are specifically adapted to 
colonise privileged sites of their hosts, such as the lymphatic system, which often 
results in a strong inflammatory response and severe disease symptoms.   
 
A bacterial infection usually involves several steps, such as the initial attachment 
and sometimes entry into the body, local or general dissemination, multiplication, 
and finally shedding from the body and transmission to new hosts. To prevent 
infections, vertebrates are equipped with exterior defences, such as the skin as a 
physical barrier and the pH of the stomach, but also innate and acquired immunity. 
During the evolutionary arms race between pathogens and their hosts, the bacteria 
have acquired a wide arsenal of cell surface structures, enzymes and toxins that 
specifically interfere with this immune response.  
 
This thesis is based on studies of the important horse pathogen Streptococcus equi 
subspecies equi. The main objective was to identify and characterise extracellular 
proteins used by S. equi subsp. equi to initiate infection and cause disease. Papers 
I,  II and IV present studies of cell surface-anchored proteins that specifically 
adhere to collagen and fibronectin, two major extracellular matrix proteins of 
vertebrates. In III a secreted immunoglobulin-specific protease is characterised. 
As a general background to these studies, the subject of S. equi subsp. equi 
infection is discussed, followed by a review of streptococcal virulence factors in 
general and the virulence factors of S. equi subsp. equi in particular. 
 
 
Streptococci and streptococcal infections 
Bacteria belonging to the genus Streptococcus are Gram-positive and catalase-
negative cocci, growing in pairs or chains. They are facultatively anaerobic, 
homofermentative and with complex nutritional requirements. The temperature 
optimum varies between streptococcal species, but is usually around 37 ºC. Some 
species form a hyaluronic acid capsule during the early phase of growth (Hardie, 
1986). The cell wall is composed mainly of cross-linked peptidoglycan, with 
carbohydrates, teichoic acid and proteins attached and exposed to the surface   8
(Fischetti, 2000). Streptococci comprise a large part of the commensal flora of 
man and animals, where they mainly colonise the mucus membranes of the mouth, 
respiratory, alimentary and genitourinary tract (Hardie & Whiley, 1995). Most 
species can act as opportunistic pathogens and some are highly virulent.  
 
One of the first characters used to differentiate isolates was the ability of certain 
clinically important streptococci to cause complete (β-) haemolysis when grown 
on solid medium containing blood (Hardie & Whiley, 1995). In 1933, Lancefield 
introduced a method to further differentiate the β-haemolytic streptococci based on 
carbohydrate ‘group’ antigens (Lancefield, 1933). The main limitation of 
Lancefield’s system is that no streptococcal species, with the exception of 
S. agalactiae, possesses a unique group antigen that can be used for identification 
to species level. In 1937, Sherman made the next major contribution to 
streptococcal taxonomy by dividing species into four major groups based on 
different phenotypic properties (Sherman, 1937). Sherman’s groups were the 
pyogenic group, the viridans (oral) group, the lactic group and the enterococci. 
Today, only the two first groups remain in the genus Streptococcus, the lactic 
group and the enterococci having been reclassified as separate genera (Hardie & 
Whiley, 1995). Since the publication of the second volume of Bergey’s Manual in 
1986, increased genotypic and phenotypic information has led to further changes 
in the genera. Several groups of Gram-positive cocci have split off the 
Streptococcus genus and new species of streptococci have been discovered, as 
reviewed by Facklam (2002). With the progress in bacterial genomics, the use of 
biochemical and serological tests to classify streptococcal isolates has largely been 
replaced by DNA-based molecular methods.  
 
A majority of the most pathogenic streptococci belong to the pyogenic (pus-
forming) group (Table 1), which mainly includes the β-haemolytic species with 
defined group antigens (Hardie & Whiley, 1995; Facklam, 2002). S. pyogenes, 
commonly referred to as Group A Streptococci (GAS), is the most common cause 
of streptococcal infection in man. Primary infection often occurs in the form of 
sore throat or skin lesions, which may become invasive and lead to potentially life-
threatening conditions such as bacteraemia, septicaemia or necrotizing fasciitis. 
S. agalactiae (Goup B Steptococci), another potent pathogen in the pyogenic 
group, is an important cause of neonatal sepsis and meningitis. The most important 
human pathogen outside of the pyogenic group, S. pneumoniae, is the major cause 
of community-acquired pneumonia. (Hardie & Whiley, 1995) 
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Table 1. The pyogenic group of streptococci 
 
Species Lancefield  group β-haemolysis Origin
S. pyogenes  A+ H u m a n
S. agalactiae  B + Human, bovine
S. dysgalactiae 
   subsp. equisimilis A/C/G/L -/+ Human,  mammals
   subsp. dysgalactiae C - Bovine
S. equi 
   subsp. zooepidemicus C + Mammals,  human
   subsp. ruminatorium C + Sheep,  goat
   subsp. equi C+ H o r s e
S. canis  G + Dog, human
S. iniae  - -/+ Dolphin, fish, human
S. parauberis  E/P - Bovine
S. porcinus  E/P/U/V/- + Swine, human
S. uberis  E/P/G - Bovine
 
The three subspecies of Streptococcus equi  
S. equi subsp. equi (for simplicity here referred to as S. equi) is a group C 
streptococcus, which typically is highly capsulated, giving large mucoid colonies 
with clear haemolytic zones when grown on blood agar. In phenotypic tests, 
S. equi is separated from related group C streptococci by its inability to ferment 
lactose, sorbitol and trehalose (Grant et al., 1993). Different isolates show very 
little serologic or antigenic variation (Galan & Timoney, 1988), and are generally 
considered as clonal. The genome is approximately 2.25 Mbp in length, with a 
G+C content of 41% (Sanger Institute, 2006). S. equi is an obligate parasite in the 
upper respiratory tract of Equidae (horses, donkeys and mules) where it causes a 
severe disease called strangles (Timoney, 1993). Unlike its related subspecies, 
S. equi is highly host-adapted, a recently reported case of strangles in dog being a 
rare exception (Ladlow et al., 2006). At least one human infection with S. equi has 
been reported, where it was isolated from the cerebrospinal fluid of a child with 
meningitis (Elsayed et al., 2003). No molecular tests were used in the 
identification though, so it cannot be ruled out that the infection was due to a 
related species with a fermentation pattern similar to S. equi.  
 
S. equi subsp. zooepidemicus ( S. zooepidemicus) is, as the name suggests, not 
strictly adapted to horses and can be found on the mucus membranes of a wide 
range of other animals, including humans. S. zooepidemicus exist as an 
opportunistic commensal, causing disease when the host is subjected to stress, for 
example due to virus infection or tissue injury (Timoney, 2004). In horses the 
most common complications include pyogenic infections of the joints, lymph 
nodes, nasal cavities, uterus and the respiratory tract. It has also been associated 
with bovine mastitis (Sharp et al., 1995). S. zooepidemicus has been associated 
with serious infections in man, including septicaemia, meningitis, pneumonia, 
septic arthritis, endocarditis and poststreptococcal acute glomerulonephritis 
(Nicholson et al., 2000; Kuusi et al., 2006). Infections have mainly been reported 
in patients over the age of 70 and can often be traced to consumption of dairy 
products, such as unpastorized cheese, which caused two recent outbreaks in Gran   10
Canaria (Bordes-Benitez et al., 2006) and Finland (Kuusi et al., 2006). The novel 
subspecies S. equi subsp. ruminatorium was recently isolated and identified from 
milk samples from sheep and goats with mastitis (Fernandez et al., 2004). 
Phenotypic and genomic assays confirmed that these new isolates were clearly 
divergent from subspecies equi and zooepidemicus, and should be given separate 
subspecies status.  
 
On the basis on DNA hybridisation, S. equi has formally been regarded as the 
archetype of S. zooepidemicus (Farrow & Collins, 1984). Later examinations of 
multilocus enzyme electrophoresis (Jorm et al., 1994) and the composition of the 
interspacer sequences for the 16S and 23S rRNA genes (Chanter et al., 1997) have 
indicated that S. equi actually evolved from an S. zooepidemicus ancestor. These 
studies and more recent analyses of the bacterial genomes (Artiushin et al., 2006; 
Mitchell et al., 2006) suggest that S. equi should be reclassified as a biovar of 
S. zooepidemicus. The ongoing annotation of the genomes of these subspecies, 
which are both accessible online (http://www.sanger.ac.uk/Projects/Microbes/), 
will give a more complete insight into their evolutionary relationship. This subject 
is discussed further in the section S.  equi subsp. equi evolved through gene 
acquisition and gene loss. 
 
Strangles 
Equine strangles, the disease caused by S. equi, is one of the most commonly 
diagnosed and serious diseases in horses. The disease and its transmission have 
been discussed in the medical literature since the late eighteenth century, and the 
first description of strangles goes back to 1251 (Timoney, 1993). Today the 
disease is spread worldwide, leading to both severe suffering in the affected 
animals and large economic losses. The following description is based on reviews 
written by Timoney (1993), Sweeney et al. (2005) and Waller & Jolly (2006).  
 
Clinical signs and conditions 
Early signs of S. equi infection are a rapid onset of fever, followed by nasal 
discharge, coughing, loss of appetite and swelling of the lymph nodes of the head 
and neck. As the disease progresses, the inflamed lymph nodes become hard and 
painful and may restrict the airway, hence the name of the disease. Abscesses in 
infected lymph nodes usually rupture within 7 to 14 days after onset of disease, 
resulting in mucopurulent drainage through the nostrils of the horse. The majority 
of animals are fully recovered from infection within a 4-6 week period. Severe 
cases of strangles are more common in younger horses, while older animals with 
residual immunity to S. equi often develop a clinically milder form of the disease. 
In severe cases, bacteria disseminate and form abscesses in other parts of the body, 
such as the lungs, brain or abdominal lymph nodes. This condition, called ‘bastard 
strangles’, often leads to death or euthanasia. Streptococcus equi infection may 
also lead to the potentially fatal condition purpura haemorrhagica, an immune 
system-mediated acute inflammation of peripheral blood vessels characterised by 
subcutaneous oedema.  
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Pathogenesis 
The infection is initiated via the mouth or nose, where bacteria attach to the 
epithelium of the tonsils and adjacent lymphoid nodules. Within a few hours the 
bacteria have been translocated below the mucosa, reaching the deeper tissues of 
the tonsils. Bacteria can be detected in the lymph nodes that drain the pharyngeal 
and tonsillar region 18 hours after experimental infection (Kumar et al., 2004; 
Timoney et al., 2006). Once inside the lymph nodes, bacterial multiplication leads 
to the release of chemotactic factors, attracting large numbers of neutrophils. High 
fever develops 3 to 12 days after experimental infection, possibly associated with 
release of pyrogenic exotoxins. By that time chains of S. equi cells, most of which 
are dead, can be observed inside the infected lymph nodes and tonsils (Kumar et 
al., 2004; Timoney et al., 2006).  
 
 
Fig. 1. Nasal discharge from a horse with strangles. Photo used with the kind permission of 
Prof. Derek C. Knottenbelt. 
 
Transmission and persistent carriage 
Nasal shedding of S. equi usually begins within 2 to 3 days after onset of fever and 
persists for 2 to 3 weeks. In many cases, however, the horse continues to harbour 
S. equi for several weeks after recovery from strangles. During this period, 
transmission of infection can continue either by direct horse-horse contact, or via 
indirect routes such as contaminated water buckets. Isolation of recovering 
animals is therefore critical to avoid spread of the disease. Furthermore, in up to 
10% of affected animals a long-term subclinical infection is established, most 
commonly in the guttural pouches (Newton et al., 1997). This asymptomatic 
carrier state can persist for months or years, and is often difficult to diagnose and 
treat (Newton et al., 2000; Verheyen et al., 2000). Some animals in the carrier 
state sporadically shed S. equi through normal nasal secretions, in that way   12
providing a source of new outbreaks. Identification of asymptomatic carriers is 
therefore critical to prevent transmission of disease.  
 
Antibiotic treatment 
Streptococcus equi is sensitive to the majority of antibiotics in vitro, but the use of 
antibiotics to treat animals with strangles remains controversial. Immediate 
delivery of antibiotics during the early acute phase of strangles usually aborts the 
infection. However, the treated animal is unlikely to develop protective immunity 
and is susceptible to reinfection after the treatment is withdrawn. At later stages of 
infection the use of antibiotics is usually not effective. This is probably due to a 
lack of sufficient vascularity in the abscess to enable effective antibiotic 
penetration (Harrington et al., 2002).  
 
Vaccination against S. equi 
The majority of animals recovering from strangles acquire a solid immunity to 
reinfection that persists for 5 years or longer (Sweeney et al., 2005; Waller & 
Jolley, 2006). This observation raised hopes for the development of an effective 
vaccine against strangles, but in spite of intensive research the progress in vaccine 
development has been slow. Early vaccines based on whole inactivated cells or 
extracts failed to provide adequate protection and often induced adverse reactions 
(Sweeney et al., 2005; Waller & Jolley, 2006). An attenuated, unencapsulated 
strain, (Pinnacle I.N.) has been on the market in the USA since 1998 (Timoney, 
2004). The Pinnacle strain has a proven protective effect, but unwanted strangles-
like symptoms have been reported following intranasal vaccination and it has not 
been licensed for sale in Europe for this reason. Another drawback with the 
Pinnacle strain is that it was developed by random chemical mutagenesis, which 
means it is prone to back-mutations that would revert the strain into an 
encapsulated phenotype. To prevent this, an improved unencapsulated mutant 
(Pinnacle HasNeg) has been generated by deleting a defined part of the has operon 
(Walker & Timoney, 2002). Another live attenuated vaccine (Equilis StrepE) has 
recently been introduced on the European market (Jacobs et al., 2000; Newton et 
al., 2005; Intervet, 2006). In order to minimise adverse reactions, the vaccine is 
injected submucosally under the upper lip of the horse. The vaccine appears to be 
safe, but the immunity is limited to a three-month period and only about 50% of 
vaccinates receive full protection following experimental infection. For this 
reason, the vaccine is only recommended for horses that are at high or moderate 
risk of infection. 
 
Protein subunit vaccines could offer an alternative to vaccines based on killed or 
attenuated bacteria. Acquired immunity appears to be primarily due to antibodies 
directed to the SeM protein and other unidentified antigens (Timoney, 2004). 
However, vaccines based on purified or recombinant SeM offer little or no 
protection (Sheoran et al., 2002; Timoney, 2004). A combination of different 
antigens is therefore likely to be necessary for a protective subunit vaccine. The 
protective immunity in horses recovered from strangles is believed to depend on a   13
combination of mucosal and serum immunoglobulins, and the failure of M 
protein-based vaccines could in part be due to the lack of an adequate mucosal 
response (Timoney & Eggers, 1985; Timoney & Trachman, 1985; Hamlen et al., 
1994; Sheoran et al., 1997). Vaccination trials have also been performed with a 
combination of three cell surface proteins (CNE, EAG and SclC) which showed 
promising results in a mouse model (Flock et al., 2004; Flock et al., 2006). 
Follow-up trials in horses vaccinated with these antigens combined with different 
adjuvants are currently being performed and will hopefully be evaluated soon.  
 
S. equi subsp. equi evolved through gene acquisition and gene 
loss 
Comparisons between the genomes of S. equi and S. zooepidemicus have shown 
about 97% sequence identity. When analysing the genomes of these closely related 
bacteria, two major factors seem to be associated with the evolution of S. equi; a 
large number of gene disruptions caused by mobile genetic elements and four 
prophage-like insertions, containing a number of potentially virulence-related 
genes. So far no genome-scale study of S. equi has been published, and for that 
reason the following discussion is largely based on conference abstracts from two 
independent groups, Artiushin et al. (2006) and Mitchell et al (2006). 
 
At present, 71 IS elements have been identified in the genome of S. equi and the 
number is likely to be somewhat higher in the final annotation of the genome 
(Matt Holden, unpublished results). These mobile genetic elements have caused 
numerous lesions in genes that are predicted to be important for the ability of the 
bacteria to adapt to changing environments, including genes involved in 
transcription regulation, quorum sensing and two component regulatory systems 
(Artiushin et al., 2006). Genetic interruptions responsible for various defects in 
nutrient transport and metabolism – such as the inability of the bacteria to ferment 
lactose, sorbitol and ribose – have also been identified (Artiushin et al., 2006; 
Mitchell et al., 2006). In this respect clear parallels can be seen in studies of the 
evolution of the genus Bordetella (Preston et al., 2004). The three bacterial species 
Bordetella pertussis, B. parapertussis and B. bronchiseptica are all closely related, 
but have different host ranges and cause different diseases. Bordetella 
bronchiseptica is closest to the evolutionary ancestor of these bordetellae and is 
asymptomatically carried by a wide range of mammals. The primarily human 
pathogens  B. parapertussis  and B. pertussis are independent derivatives of 
B. bronchiseptica, and genome analysis suggests that they evolved primarily due 
to loss of gene function caused by insertion of a large number of IS elements. 
Another more closely related species that evolved mainly through loss-of-function 
events is Streptococcus thermophilus (Bolotin et al., 2004), the only ‘Generally 
Recognized as Safe’ species within the genus Streptococcus. In this species the 
adaptation to a constant milk environment has led to the inactivation of most of the 
streptococcal virulence-related genes.  
 
It has long been known that phage-mediated gene transfer plays an important role 
in the evolution and virulence of pathogens (Brussow et al., 2004). With the   14
advent of bacterial genome sequencing, a large number of new prophages have 
been discovered, which has led to increased interest in this area of research. In the 
genome of S. equi, the majority of the genes that have no homologues in 
S. zooepidemicus have been located in four prophage-like insertions. These genes 
include previously reported virulence factors such as the pyrogenic mitogens 
SeeH, SeeI, SpeL, SpeM, but also a putative phospholipase with high similarity to 
the Sla toxin of S.  pyogenes M3, a potential mitogen with similarity to the 
streptodornase of S. pyogenes M3 and a hyaluronidase that is required for phage 
penetration of the bacterial capsule (Mitchell et al., 2006; Tiwari et al., 2006). 
Interestingly, the Sla and streptodornase homologues are located in two separate 
prophages in both S. equi  and  S. pyogenes M3, highlighting the importance of 
gene transfer between these closely related species. It has been proposed that the 
recent acquisition of Sla by S. pyogenes M3 (Beres et al., 2002) may have 
occurred via phage-mediated transfer from S. equi (Mitchell et al., 2006).  
 
To summarise, the rapid IS element expansion in the genome of S. equi has led to 
numerous interruptions of genes with important functions for the ability of the 
bacteria to adapt to changing environments. Loss of gene function therefore seems 
largely accountable for the inability of S. equi to colonise mucosal surfaces. The 
acquisition of virulence-related genes through phage-mediated transfer, on the 
other hand, has most likely been essential for the bacteria in its adaptation to a new 
and unique ecological niche.  
 
Extracellular proteins of streptococci 
Extracellular proteins, which here collectively refers to secreted and cell surface-
located proteins, are believed to play an important role in the process of infection 
and in bacterial survival inside the host. This section describes the general 
characteristics of streptococcal cell surface-anchored proteins, while the next 
section discusses the importance of some of these proteins in more detail. 
 
The streptococcal cell wall 
The streptococci, like other Gram-positive bacteria, are surrounded by a rigid cell 
envelope made from cross-linked peptidoglycan (Navarre & Schneewind, 1999). 
This large macromolecule works as a physical barrier, protecting the bacteria 
against both mechanical and osmotic lysis. The cell wall also serves as a scaffold 
for the attachment of proteins, teichoic acids and polysaccharides that are exposed 
from the bacterial surface. Three different mechanisms of anchoring proteins to 
the cell surface are common among the streptococci (Ton-That et al., 2004) 
(Fig. 2): (i) Sortase-mediated attachment of proteins with LPxTG-type motifs to 
the cell wall; (ii) N-terminal linkage to lipids of the underlying cell membrane 
(lipoproteins); and (iii) binding by charge or hydrophobic interaction. In S. equi, 
as in the other streptococci, the majority of all cell surface proteins studied are 
predicted to be sortase-attached.    15
 
Fig. 2. Schematic presentation of the major surface structures of the streptococcal cell wall 
(modified from Fischetti, 2000). Surface proteins can be linked to the cytoplasmic 
membrane through a cysteine in the N-terminus (lipoproteins), to the peptidoglycan through 
a C-terminal LPxTG motif (sortase-anchored proteins) or to the cell surface by charge or 
hydrophobic interactions. Other proteins are secreted to the growth medium. Linked to the 
outer surface of the streptococcal cell wall are polysaccharide structures that are used in 
some cases for their immunological classification. Teichoic acids (TA) span through the 
cell wall and can be linked to the peptidoglycan, or as the lipoteichoic acids (LTA) to fatty 
acids of the cytoplasmic membrane. 
 
Export of extracellular proteins 
Proteins that are destined to the outside of bacterial cells are labelled with an 
N-terminal signal peptide (signal sequence) that is proteolytically removed upon 
translocation across the cell membrane (Fig. 3). The signal peptide is characterised 
by short sequence of positively charged residues in the N-terminal end, followed 
by a central hydrophobic region and a C-terminal cleavage site with small, 
uncharged residues in the -3 and -1 positions relative to the cleavage site (von 
Heijne & Abrahmsen, 1989). The signal peptides of Gram-positive bacteria are 
usually longer than those of Gram-negatives, with a mean length of around 29-31 
aa. Cell surface proteins require an additional topogenic sequence to be correctly 
located to the surface, such as a lipobox for lipoproteins or a C-terminal sorting 
signal for sortase-anchored proteins. Proteins with signal peptides that lack this 
additional motif are normally released into the extracellular milieu. A number of 
enzymes with important functions in streptococcal virulence are secreted in this 
manner. 
 
Sortase-anchored proteins 
Sortase-anchored proteins are characterised by a C-terminal cell wall sorting 
signal, spanning approximately 30 to 40 residues (Marraffini et al., 2006). This 
sequence starts with an LPxTG motif, followed by a stretch of hydrophobic 
residues and a mostly positively charged tail in the C-terminal end (Fig. 3). The 
hydrophobic domain and the charged tail are thought to arrest the transport of the 
protein from the cytoplasm, placing the LPxTG motif at the outer surface of the 
cell membrane. The LPxTG motif is then recognised by the membrane-associated 
enzyme sortase, which cleaves it between the threonine and the glycine residues   16
and covalently links the carboxy-end of the threonine to the peptidoglycan 
(Navarre & Schneewind, 1999). The cell wall sorting signal, including the LPxTG 
motif, is useful in the bioinformatic identification of genes for cell wall-bound 
proteins. In many bacterial species, however, the sortase substrate motifs tend to 
deviate from the LPxTG pattern (Boekhorst et al., 2005). Among the predicted 
cell surface proteins of S. equi, LPxTN appears to be a common variant (IV).  
 
A recently discovered function of sortases that has received great attention is their 
participation in the assembly of pili in Gram-positive bacteria (Ton-That & 
Schneewind, 2004; Marraffini et al., 2006). In this process, the sortase is believed 
to catalyse the polymerisation of proteins with LPxTG motifs into an extended 
filament, often with an adhesive component at the tip. Pili of this type have been 
identified in a number of streptococcal species, including S. pyogenes and 
S. agalactiae (Mora et al., 2005; Dramsi et al., 2006). 
 
Fig. 3. Domain organisation of a characteristic sortase-anchored surface protein. SS, signal 
sequence; W, wall spanning region; M, membrane spanning region. 
 
Common structures and functions of cell wall-anchored proteins 
Streptococcal cell wall-anchored proteins display a wide variety of different 
structures and functions. A common domain in almost all cell wall-anchored 
proteins is a 50-125 aa long proline/glycine or threonine/serine-rich sequence, 
located next to the LPxTG motif (Fischetti, 2000). This part of the protein is 
positioned within the cell wall. The part of the protein that is exposed outside the 
cell contains the functional domain(s) and is therefore typically unique. In many 
proteins, however, the C-terminal part contains a set of repeated sequence blocks 
of varying lengths (Navarre & Schneewind, 1999). In some proteins this repetitive 
region displays binding activity, but in others it is believed to function merely as a 
spacer region, exposing the functional domain from the cell.  
 
The most commonly studied functions of cell wall-anchored proteins are the 
binding to host tissues, plasma proteins and specific immune system components. 
In this respect they stand in contrast to lipoproteins, which are more commonly 
involved in transport systems, often involving uptake of nutrients (Sutcliffe & 
Russell, 1995). Bacterial proteins, cell-bound or soluble, that specifically interact 
with host tissue or plasma components are generally called receptins (Kronvall & 
Jonsson, 1999). The commonly used term adhesin is more narrow, specifically 
referring to proteins that the bacteria use to adhere to host tissues. Other cell wall-
anchored proteins function as enzymes, often proteases, with the catalytic site 
exposed to the surrounding environment.    17
Bacterial binding to components of the extracellular matrix  
Adherence to host tissues is the first step in bacterial infection, and in Gram-
positive pathogens this initial attachment is to a large extent mediated by cell 
surface proteins. The majority of the known bacterial adhesins specifically interact 
with components of the extracellular matrix (ECM) and are therefore commonly 
referred to as MSCRAMMs (microbial surface components recognising adhesive 
matrix molecules) (Patti et al., 1994). Common ligands for MSCRAMMs include 
fibronectin, collagen, laminin and elastin. This section describes two major ECM 
components that are important in the present study, fibronectin and collagen, and 
how the attachment to these ligands is exploited by Gram-positive pathogens.  
 
Fibronectin 
Fibronectin (Fn) is a large and complex glycoprotein, which usually exists as a 
dimer of two nearly identical subunits (250-280 kDa) linked near their C-termini 
by a pair of disulphide bonds. Fibronectin is involved in several important 
biological processes in vertebrates, including cell adhesion, migration, growth and 
differentiation (Pankov & Yamada, 2002). These biological interactions are 
mediated by a number of functional domains that interact with cellular integrins, 
collagen/gelatin, heparin, fibrin and other ligands. Fibronectin is present both in 
soluble form in plasma and other body fluids (termed plasma Fn), and in insoluble 
form as part of the extracellular matrix (cellular Fn). Cellular Fn constitutes a 
larger and more heterogeneous group of different isoforms, resulting from cell- 
and species-specific mRNA splicing patterns (Pankov & Yamada, 2002). 
Approximately 90% of the Fn sequence consists of three repetitive sequences that 
form distinct modules: 12 F1 modules, two F2 modules and 15-17 F3 modules 
(Fig. 4). Fibronectin is only cleaved at specific non-folded, unprotected sites when 
subjected to limited proteolytic digestion, and the resulting fragments are 
commonly used to locate the different active sites of the molecule.  
 
Fig. 4. Modular representation of one Fn chain. F1 modules are in black, F2 modules in 
white and F3 modules in grey. The number of F3 modules varies due to differences in RNA 
splicing. Arrows mark the major proteolytic digestion sites. The molecular weights of the 
resulting fragments, and their major ligand interactions, are indicated. 
 
Collagens 
Collagens, the most abundant structural components of the ECM, are a family of 
proteins that form a characteristic rope-like right-handed helix of three polypeptide 
chains. Up to now, 26 different collagen types have been identified, most of which 
show diverse functions and tissue distributions, but all with at least one triple-  18
helical domain formed by a number of Gly-x-y repeats (Gelse et al., 2003; Ricard-
Blum & Ruggiero, 2005). Collagens can be assembled by three identical peptide 
chains (homotrimers) or by a combination of different chains (heterotrimers). The 
collagen superfamily serves a number of different biological functions, but most 
noticeably they function by forming highly organised polymers that contribute to 
the structural integrity of the extracellular matrix. Collagens can be grouped in two 
main classes based on the type of polymers formed; the fibril-forming collagens 
(collagens I, II, III, V and XI), which represent a rather homogeneous group, and 
the more heterogeneous group of nonfibrillar collagens (Aumailley & Gayraud, 
1998). Collagen fibrils are supramolecular aggregates that give tissues such as 
tendons, bone, cartilage and skin the ability to resist tear, tensile stress and 
pressure (Bosman & Stamenkovic, 2003). A major nonfibrillar sub-group is the 
network-forming collagens (IV, VIII and X), which form a large part of the 
basement membrane (Bosman & Stamenkovic, 2003). 
 
Fig. 5. Cartoon representations of two common models of bacterial binding to components 
of the extracellular matrix. A: In the β-zipper model, the Fn-binding repeat forms an 
additional antiparallel strand to the F1 modules of the 29-kDa fragment of Fn. Modified 
from Schwarz-Linek et al., (2004). B: In the collagen hug model, the collagen triple helix is 
initially associated with the N2 domain of CNA, and then wrapped by the N1-N2 linker and 
the N1 domain. Modified from Zong et al. (2005). 
 
Bacterial proteins with fibronectin-binding repeats 
Fibronectin-binding adhesins are common among streptococci, staphylococci and 
other Gram-positive pathogens. The majority of these proteins specifically bind to 
the N-terminal 29-kDa fragment of Fn with a sequence of conserved repeats: 
ED(T/S)(X9,10)GG(X3,4)(I/V)DF (Table 2). Some proteins in this family also 
display an additional binding region that interacts with the adjacent 40-kDa 
fragment of Fn. The Fn-binding repeats are typically located in the C-terminal end, 
next to the cell wall-spanning region. The N-terminal part of these proteins often 
contains additional binding sites, in some cases with enzymatic properties, which   19
gives them mosaic-like structures of different functional domains. The properties 
of this family of Fn-binding proteins have been discussed in a number of recent 
reviews (Schwarz-Linek et al., 2004; Hauck & Ohlsen, 2006; Schwarz-Linek et 
al., 2006). The structure of typical Fn-binding repeats in complex with the 29-kDa 
Fn domain has been determined using NMR spectroscopy (Schwarz-Linek et al., 
2003; Pilka et al., 2006). An unusual feature of this model is that the Fn-binding 
repetitive part of the protein has a free, linear conformation in solution, which 
upon binding to Fn forms an additional antiparallel strand to the β-sheet structure 
of the N-terminal F1 modules (Fig. 5).  
 
Interestingly, Fn-binding proteins of S. pyogenes and Staphylococcus aureus have 
both been confirmed to mediate internalisation in several non-professional 
phagocytes, including epithelial and endothelial cells (Ozeri et al., 1998; Sinha et 
al., 1999). This process starts with the recruitment of plasma Fn to the bacterial 
surface. Upon binding, a conformational change is triggered in Fn, leading to the 
exposure of the integrin-binding RGD motif, which is cryptic in soluble Fn 
(Tomasini-Johansson et al., 2001). Fn-integrin interactions lead to integrin 
clustering on the cell surface, which triggers signalling pathways leading to 
cytoskeleton rearrangements and bacterial uptake through membrane 
invaginations (Schwarz-Linek et al., 2004; Hauck & Ohlsen, 2006). This 
mechanism of invasion might help the bacteria evade host immune responses and 
has been linked to persistent bacterial infections. It has also been suggested that 
intracellular survival of S. pyogenes contributes to penicillin treatment failures.  
 
Studies to evaluate the role of Fn-binding proteins in experimental infections have 
led to unexpected and seemingly conflicting results. In two separate experiments, 
S. pyogenes strains lacking Fn-binding proteins (SOF and FbaB, respectively) 
were used in experimental mouse infections, both resulting in decreased mouse 
mortality (Courtney et al., 1999; Terao et al., 2002). However, the observed effect 
could not be conclusively linked to a lack of cellular binding to Fn in either of 
these studies. In a more recent study, the gene for protein F1 was introduced into a 
S. pyogenes strain lacking this gene (Nyberg et al., 2004). Surprisingly, these F1-
expressing bacteria were less virulent than the F1-negative strain in a mouse 
model. The virulence of these bacteria was partially restored when the bacteria 
were used to infect mice lacking plasma Fn, confirming that the decrease in 
virulence could be attributed to the Fn-binding activity of F1. Furthermore, 
infections with F1-negative bacteria caused an increased bacterial dissemination to 
the spleen, compared to the more localised infections caused by F1-expressing 
bacteria. A similar enhancement of virulence has been observed in a FnBP-
negative strain of S. aureus when used in a rat model of pneumonia (McElroy et 
al., 2002). Together, these experiments indicate that the Fn-binding activity of 
S. pyogenes and S. aureus leads to less virulent infections, as the bacteria are being 
immobilised by host cells and tissues.    20
Table 2. Proteins with Fn-binding repeats recognising the 29-kDa fragment of Fn. Most of 
these proteins are multi-functional with additional binding or enzymatic properties 
 
Species Name Additional  function Reference
S. aureus  FnBPA Elastin- and Fg-
binding
(Signas et al., 1989; Wann et 
al., 2000; Roche et al., 2004)
 FnBPB Elastin-binding (Jonsson et al., 1991; Roche 
et al., 2004)
S. pyogenes  SfbI / F1 Fibrinogen-binding (Hanski & Caparon, 1992; 
Talay et al., 1992; Katerov et 
al., 1998)
  Pfbp / F2 (Jaffe et al., 1996; Rocha & 
Fischetti, 1999; 
Ramachandran et al., 2004)
 SOF/SfbII Lipoproteinase (Rakonjac et al., 1995; 
Kreikemeyer et al., 1999)
  FbaB / F2 (Jaffe et al., 1996; 
Ramachandran et al., 2004)
 SfbX (Jeng et al., 2003)
S. dysgalactiae  SOF/FnBA Lipoproteinase (Lindgren et al., 1992; 
Katerov et al., 2000)
 FnBB (Lindgren et al., 1992)
S. zooepidemicus  FNZ Collagen-binding (Lindmark et al., 1996)
  FNZ2 Collagen-binding (Hong, 2005)
S. equi  FNEB (II)
Borrelia burgdorferi  BBK032 (Probert et al., 2001)
 
 
Collagen-binding bacterial proteins 
The best studied collagen-binding adhesin of Gram-positive cocci is CNA of 
S. aureus (Patti et al., 1992), and the crystal structure of the binding region of this 
protein was recently published (Zong et al., 2005). In contrast to the Fn-binding 
proteins described above, the binding region of CNA forms two separate 
subdomains with fixed three-dimensional structures. These two domains attach to, 
and wrap around, the collagen monomer in a binding model called ‘collagen hug’ 
(Fig. 5). The proposed model explains why CNA does not bind to gelatine or 
denatured collagen. Similar collagen-binding proteins have been found in a 
number of Gram-positive pathogens, forming what appears to be a family of 
evolutionary related homologues (Table 3). Typically, the N-terminal half of these 
proteins contains the collagen-binding domain (A-domain), which is followed by a 
number of repeats (B-repeats) and a cell wall-anchor domain in the C-terminus. 
Unlike the Fn-binding proteins previously described, these proteins have no 
mosaic structures of different functional domains. The B-repeats have no known 
function other than to expose the active A-domain away from the cell. No CNA-
homologue has been found in S. pyogenes, but some strains express an unrelated 
collagen-binding adhesin called CPA (Podbielski et al., 1999). Interestingly, the 
predicted three-dimensional structure of the CPA collagen-binding site resembles 
the active site of CNA, suggesting that these proteins have acquired a similar 
structure through convergent evolution (Kreikemeyer et al., 2005). CNA-deficient 
isogenic mutants have been used to confirm that CNA is a virulence factor in 
animal models of staphylococcal keratitis, endocarditis, osteomyelitis and septic 
arthritis (Hienz et al., 1996; Rhem et al., 2000; Elasri et al., 2002; Xu et al., 2004),   21
which indicates that the ability to bind collagen is advantageous for the bacteria in 
several different types of infection.  
 
Table 3. The CNA family of collagen-binding proteins 
 
Species Name  Reference 
S. aureus  CNA (Patti et al., 1992) 
S. equi  CNE (I) 
Streptococcus mutans  CNM (Sato et al., 2004) 
Enterococcus faecalis  ACE (Rich et al., 1999) 
Enterococcus faecium  ACM (Nallapareddy et al., 2003) 
Bacillus anthrasis  BA0871 (Xu et al., 2004) 
  BA5258 (Xu et al., 2004) 
 
 
Fibronectin- and collagen-binding proteins as vaccine components 
The important functions of bacterial adhesins in the early phase of bacterial 
infections make them promising as components in subunit vaccines (Wizemann et 
al., 1999). The proposed strategy has been to block the initial bacterial attachment 
with adhesin-specific antibodies at the site of infection. However, the level of 
success for adhesin-based vaccines or for subunit vaccines in general has been 
very limited to date (Moxon & Rappuoli, 2002; Grandi, 2003; Scarselli et al., 
2005; Serruto & Rappuoli, 2006). A common difficulty in vaccination trials is to 
induce a strong and lasting immune response at the mucosal level. Furthermore, 
most bacteria express a large number of adhesins that can compensate for each 
other during infection. An immune response against a specific combination of 
surface antigens might therefore be necessary to successfully block bacterial 
binding. To complicate matters further, several bacterial pathogens display strain-
specific antigenic variations in their surface proteins. A broad-range vaccine must 
therefore induce an immune response directed to conserved epitopes of proteins 
that are common among different strains of the bacteria in question. This has been 
a great obstacle in the development of vaccines against S. pyogenes and other 
pathogens with great antigenic variation, but will probably not be as much of a 
problem with more homologous bacterial species such as S. equi.  
 
Proteins with Fn-binding repeats have shown potential as vaccine components in 
several animal studies, including a rat model for S. aureus endocarditis and a 
mouse model for S. pyogenes infection (Rennermalm et al., 2001; Schulze et al., 
2003). In contrast, no protection was observed in a mouse model for S. equi 
infection (Flock et al., 2006). The observed protection is however most likely due 
to an antibody-mediated bacterial clearance by phagocytes (opsonisation). It has 
been reported that these antibodies actually recognise the Fn-binding proteins in 
complex with Fn and therefore do not prevent, but could actually enhance, the 
binding (Speziale et al., 1996; Casolini et al., 1998). The reason for this failure to 
generate neutralising antibodies could be that the ‘free’ Fn-binding region is 
poorly immunogenic due to the lack a secondary structure, or simply that Fn-
binding proteins quickly form complexes with plasma Fn before they are 
recognised by the immune system.    22
A recombinant fragment of CNA has been shown to be effective in protecting 
mice against S. aureus-induced septic death (Nilsson et al., 1998). Antibodies 
against CNA have also been shown to effectively interfere with the attachment of 
S. aureus to a collagen substrate (Visai et al., 2000). Likewise, the use of CNE in a 
strangles model in mice gave encouraging results, and the same study showed that 
serum antibodies against CNE were able to block the binding of S. equi to 
immobilised collagen (Flock et al., 2006).  
 
 
Potential virulence factors of Streptococcus equi subsp. equi 
 
The exact definition of the term virulence factor has been a matter of debate, but it 
is generally defined as a component of a pathogen that fulfils molecular Koch’s 
postulate, i.e. the deletion of the gene associated with the trait specifically impairs 
virulence (Casadevall & Pirofski, 1999; Falkow, 2004). To separate virulence 
factors from fitness factors, it is often implied that the deletion should not lead to a 
decrease in general viability. Factors that are believed to be important in the 
virulence of S. equi include the carbohydrate capsule, several surface proteins and 
a number of toxins. To date, however, only a few S. equi deletion mutants have 
been made and used in infection models. For that reason these factors are here 
collectively referred to as potential virulence factors.  
 
Capsule 
S. equi display an highly encapsulated phenotype when grown on blood agar, 
giving the colonies a ‘honeydew’ appearance. This hyaluronic acid capsule is non-
antigenic and has in several studies been associated with virulence and resistance 
to phagocytosis. The encapsulation in liquid growth media is greatly influenced by 
culture age, as young cultures (4-6 h) are highly encapsulated, whereas the 
encapsulation of overnight cultures is barely detectable (Harrington et al., 2002). 
Infection experiments in mice and foals have both shown that young cultures are 
significantly more virulent and also more resistant to phagocytosis (Harrington et 
al., 2002). A study by Anzai et al. (1999) confirmed that resistance to 
phagocytosis is also correlated with levels of encapsulation when strains with 
different expression of capsule are compared. Mutants completely lacking a 
capsule are unable to colonise the lymph nodes of experimentally infected horses 
(Timoney et al., 2006). Hyaluronidase treatment of S. equi cells results in a slight 
increase in adherence to tongue cells of ponies, suggesting that heavy 
encapsulation partially covers the active sites of adhesins that are expressed on the 
cell surface (Srivastava & Barnum, 1983).   
 
M-like proteins 
The M protein family of S. pyogenes is an extensively studied class of cell surface-
anchored proteins that extend from the surface as alpha-helical coiled-coil dimers 
(Cunningham, 2000). The N-terminal region is often hypervariable and induces 
opsonic antibodies that normally do not cross-react with other M types. An 
important function of the M proteins is to enable the bacteria to resist   23
phagocytosis, or even facilitate intracellular survival inside neutrophils (Staali et 
al., 2003). The antiphagocytic properties of the M proteins depend on binding to 
fibrinogen (Fg) or to human C4b-binding protein, which in turn prevents the 
deposition of complement factors on the bacterial surface (Carlsson et al., 2005). 
The ‘M-like proteins’ of related streptococci often refer to Fg-binding proteins 
with antiphagocytic activity, and these proteins may or may not be structurally 
related to the M proteins of S. pyogenes.  
Fig. 6. Schematic representation of the SeM protein, adapted from Kelly et al. (2006). The 
region found deleted in 24% of S. equi strains isolated from subclinical carriers, the variable 
region used in subtyping of strains and the Fg- and IgG-binding regions are indicated. 
 
In S. equi two M-like proteins have been studied, SeM (also known as FgBP) 
(Fig.  6) and SzPSe. These proteins show no significant sequence similarity 
between each other, or to the M proteins of S. pyogenes, but both have extended 
regions of alpha-helical coiled-coils and bind strongly to equine Fg (Timoney et 
al., 1997; Meehan et al., 2002). In addition, SeM binds to IgG-Fc (Meehan et al., 
2001). SzPSe is the S. equi homologue of the S. zooepidemicus protein SzP, but 
SeM has been regarded as unique to S. equi, and the acquisition of the gene 
encoding this protein has been proposed to be an important step in the evolution of 
this subspecies  (Timoney et al., 1997). However, recent genome studies have 
shown that S. zooepidemicus indeed encodes an allelic variant of SeM, denoted 
SzM (Kelly et al., 2006). This protein shows no significant similarity to SeM in 
the N-terminal region, which is necessary for the binding of SeM to Fg and IgG-
Fc, so it is possible that the replacement or modification of this region, rather than 
the acquisition of the whole protein, represents the important evolutionary step. 
SeM is the major cell wall-associated protein of S. equi  cells grown in vitro 
(Meehan et al., 1998) and antibodies to this protein are strongly opsonogenic in 
whole blood or with purified neutrophils (Boschwitz & Timoney, 1994) 
Antibodies to SzPSe, on the contrary, have no opsonic effect and the protein is not 
believed to be as important in resistance to phagocytosis (Timoney et al., 1995). 
The importance of SeM as a virulence factor was demonstrated in a study where a 
knockout mutant lacking this protein was employed in a number of experiments 
(Meehan et al., 2001). The mutant failed to autoaggregate when it reached the 
stationary phase under the conditions of laboratory growth, bound no Fg or IgG, 
was rapidly killed in horse blood and showed decreased virulence in a mouse 
model. Mutants lacking SeM are also unable to colonise the lymph nodes of 
experimentally infected horses (Timoney et al., 2006). 
 
Studies on the cross-reactivity of convalescent horse sera and Southern blots with 
a  sem probe have suggested that SeM is highly homogeneous across different   24
bacterial isolates (Galan & Timoney, 1988). Exceptions were found in a study of 
long-term carriers with subclinical infections of the guttural pouches, where 24% 
of the isolates harboured genes with slightly different in-frame deletions of the 
5’ end encoding the N-terminal part of the mature protein (Chanter et al., 2000). 
The deletions covered a part of the protein associated with Fg-binding, located 
between the signal sequence and the central repeat region (Fig 6). This N-terminal 
part of SeM thus seems necessary for full virulence, and the deletion might 
represent an escape mutation from the immune response of the horse that 
facilitates a prolonged infection (Chanter et al., 2000). Isolates with these 
truncations were more susceptible to phagocytosis in vitro than typical isolates. 
Following this study, two independent groups have found several minor 
differences in the 5’ end of the gene encoding SeM, and have shown that they can 
be used in the subtyping of different isolates (Anzai et al., 2005; Kelly et al., 
2006). A combination of the results of these studies led to the identification of 43 
different alleles of SeM (excluding alleles with changes in the signal sequences) 
(Waller & Jolley, 2006). The ratio of non-synonymous to synonymous 
substitutions in this variable region of SeM indicates that it is under high 
immunological pressure.  
 
Released M proteins of S. pyogenes have recently been reported to induce 
inflammatory responses by two different mechanisms; direct activation of 
monocytes by interaction with TLR2 (Pahlman et al., 2006) and, when forming 
complexes with fibrinogen, by activation of neutrophils (Herwald et al., 2004). No 
similar inflammatory effect by M-like proteins of S. equi has been reported, but if 
such a property could be confirmed it would provide a good explanation for the 
reduced clinical symptoms observed in horses infected by S. equi with truncated 
protein SeM.  
 
Table 4. Potentially virulence-related extracellular proteins of S.  equi. Anchoring or 
secretion is in most cases predicted and not experimentally verified. Only published 
proteins are included 
 
Name Anchored 
or secreted
Function In 
S. zooepidemicus
CNE Anchored Collagen-binding  CNZ?
EAG Anchored α2M-, albumin and IgG-binding  ZAG
FNE  Secreted Collagen- and Fn-binding  FNZ
FNEB Anchored Fn-binding  FNZ2
IdeE Secreted IgG-peptidase  IdeZ
SclC-SclI Anchored Unknown  -
SeM  Anchored Fg- and IgG-binding  SzM
SePE-H (SeeH)  Secreted Exotoxin  Not detected
SePE-I (SeeI)  Secreted Exotoxin  Not detected
SpeL (SeeL)  Secreted Exotoxin  SzeL
SpeM (SeeM)  Secreted Exotoxin  SzeM
SFS Secreted Fn-binding  SFS
SzPSe Anchored Fg-binding  SzP
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Other receptins and adhesins 
EAG is the S.  equi equivalent of ZAG, a plasma protein receptin of 
S. zooepidemicus that specifically binds to albumin, IgG and the protease inhibitor 
α2-macroglobulin (α2M) (Jonsson et al., 1995). In Northern blots no transcripts of 
the gene encoding EAG could be detected from cells grown in laboratory cultures 
(Lindmark, 1999). Consequently, the binding of S. equi cells grown in vitro to IgG 
is reported to be very low (Lindmark et al., 1999) and mediated primarily by SeM 
(Meehan et al., 2001). Based on these data, the importance of EAG as a virulence 
factor could be questioned. However, measurements of antibody titres specific to 
EAG in convalescent horses can provide indirect evidence for the in vivo 
expression of EAG during S. equi infection (Flock et al., 2004).  
 
Three different Fn-binding proteins of S. equi have so far been published. FNE is a 
homologue of FNZ of S. zooepidemicus. FNZ contains two different Fn-binding 
domains: a region with typical repeats in the C-terminal end that interacts with the 
29-kDa fragment of Fn, and an hitherto uncharacterised 40-kDa fragment binding 
domain in the N-terminal half of the protein (Lindmark et al., 1996; Lindmark et 
al., 2001) (II). However, the gene encoding FNE is interrupted by a frameshift 
mutation, leading to the transcription of a truncated protein without the 29-kDa 
binding repeats or the C-terminal cell wall anchor domain of FNZ (Fig.  7) 
(Lindmark et al., 2001). FNE has consequently been found released in the medium 
during  S. equi cultivation. Interestingly, the N-terminal half of FNZ, which is 
identical to the entire protein FNE, was recently found to bind collagen in addition 
to Fn (Liden et al., 2006). Four new putative paralogues to FNE have been found 
in S. equi, all of which bind collagen to different degrees and one that binds Fn. 
These are discussed in the section Present investigation. Another Fn-binding 
protein (SFS) also binds the 40-kDa fragment (Lindmark & Guss, 1999) (II). SFS 
lacks any putative cell-wall anchoring domains, and has for that reason been 
predicted to be a secreted protein. However, the in vitro expression of SFS is low, 
and no protein has been detected in growth cultures. Finally, FNEB is the only 
published Fn-binding protein of S. equi that appears to be anchored to the cell wall 
(II). FNEB contains typical Fn-binding repeats and specifically interacts with the 
29-kDa fragment. This protein is further described in the section Present 
investigation. 
 
Seven different proteins with collagen-like repeats (SclC-SclI) have been studied 
in S. equi (Karlstrom et al., 2004; Karlstrom et al., 2006). The C-terminal parts of 
these proteins contain similar collagen-like repeats, and in the N-terminal ends 
each have a unique A-domain with no significant similarities to any known 
proteins. Two proteins with similar collagen-like repeats have been found in 
S. pyogenes, and these have been shown to form triple helices and interact with 
mammalian collagen-binding integrins (Xu et al., 2002; Humtsoe et al., 2005). 
Wether the Scl-family of proteins in S. equi have similar structures and biological 
functions remains to be investigated.    26
Secreted toxins and enzymes  
Streptococcus equi has acquired genes for at least four mitogenic exotoxins by 
phage-mediated transfer. These toxins are believed to function as superantigens 
and misdirect the immune response by activating a large number of T cells. This 
activation leads to a massive release of pro-inflammatory cytokines, which is 
likely to contribute to the severe symptoms of strangles, such as high fever and 
neutrophilia (Anzai et al., 1999). Two of these toxins (SePE-H and SepE-I) are 
located in the same phage-associated locus and are almost identical to their 
counterparts in S. pyogenes. Both proteins have been shown to induce a strong 
mitogenic response in horse peripheral blood monocytes and pyrexia in rabbits, 
but only SEPE-I is pyrogenic in ponies (Artiushin et al., 2002). The two other 
superantigens (SPE-L and SPE-M) also share high sequence similarity to 
orthologues found in S. pyogenes (Proft et al., 2003). In a recent study, the genes 
for these two superantigens were also found in one out of 31 strains of 
S. zooepidemicus (Alber et al., 2005).  
 
Studies of the β-haemolysis in S. equi cultures under different growth conditions 
have suggested that this activity is due to a Streptolysin S-like toxin (Flanagan et 
al., 1998). Production of the haemolysin is induced during logarithmic growth and 
is dependent on a serum supplement. However, the gene(s) responsible for the 
observed activity have not yet been published. The precise role of this toxin is not 
known, but the lysis of neutrophils and macrophages is expected to be important 
in immune evasion (Harrington et al., 2002). This lytic activity is also likely to 
make essential nutrients available to the bacteria.  
 
Streptococcus equi also secretes a streptokinase that specifically activates equine 
plasminogen and thereby induces the hydrolysis of fibrin (McCoy et al., 1991). 
The function of this streptokinase in infection has not been proven, but it is 
possible that the hydrolysis of fibrin clots could aid bacterial spread.   
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“Sometimes you make the right decision, 
 sometimes you make the decision right” 
Dr Phil 
 
 
Present investigation 
The main objective of this study was to identify and characterise new potential 
virulence factors expressed by S. equi. The focus was mainly on cell surface 
proteins that specifically adhere to collagen and fibronectin (I, II, IV), two major 
extracellular matrix proteins of vertebrates, but a secreted immunoglobulin-
specific protease was also studied (III). A useful tool in this research was the 
publicly available S. equi genome, which can be used to identify homologues to 
virulence-associated proteins of related pathogens such as S. pyogenes and 
S. aureus. This genome database was also useful in identifying potential 
paralogues to previously characterised proteins (IV). The present study was 
mainly of a basic science nature, but had also the applied objective of identifying 
components for a future vaccine against strangles.  
 
CNE, a collagen-binding protein of S. equi subsp. equi (I) 
The collagen-binding protein CNE belongs to a putative family of structural and 
functional homologues of Gram-positive cocci described in a previous section. In 
this study, we expressed recombinant proteins corresponding to the mature protein 
(CNE L) and the collagen-binding ‘A domain’ (CNE S) (Fig. 7). These 
recombinant proteins were used in a Western ligand blot to confirm that CNE 
bound to 
125I-labelled bovine collagen type I, and that the binding activity was 
located in the A domain. It was possible to inhibit the binding of soluble 
radiolabelled collagen to immobilised CNE S in microwells with increasing 
concentrations of CNE S, indicating that the binding was specific. In a similar 
manner, it was possible to inhibit the binding between collagen and immobilised 
CNE S with recombinant CNA, confirming that the two proteins were competing 
for the same binding site in collagen.  
 
CNE S was used to inhibit the binding of radiolabelled collagen to S. equi cells in 
solution, but the binding could only be reduced to 65%. The reason for this 
incomplete inhibition could be that multiple binding sites on collagen in 
combination with a high cellular expression of CNE make complete inhibition 
unattainable, or that the cellular binding to collagen is due to the combined activity 
of CNE and an unidentified surface structure. When S. equi cells were incubated 
in solution with radiolabelled CNE S and increasing concentrations of collagen, 
the radioactivity bound to the cell pellet was proportional to the amount of added 
collagen, indicating that CNE binds to multiple binding sites on the collagen 
monomer.  
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Fig. 7. Schematic representation of the extracellular proteins in the present study. The 
recombinant proteins used are represented as bars, with lengths in amino acids and 
molecular weights indicated. Roman numerals in brackets show the papers in which the 
recombinant proteins were used.    29
The gene encoding CNE was detected in all isolates of S. equi  and 
S. zooepidemicus tested. Today, the gene encoding the CNE-homologue of 
S. zooepidemicus can be found in the publicly available S. zooepidemicus genome 
database. However, the protein encoded by this gene has not been studied. 
 
Since the completion of this study, CNE has been evaluated as a vaccine 
component in a strangles model in the mouse (Flock et al., 2006). Vaccination 
with CNE prior to experimental infection resulted in a low but statistically 
significant decrease in clinical symptoms, measured as weight loss and nasal 
shedding. Interestingly, CNE had an immunostimulatory effect on the poorly 
immunogenic protein EAG, and a coadministration of CNE and EAG resulted in a 
synergistic protective effect. The same study showed that serum antibodies against 
CNE were able to block the binding of S. equi to immobilised collagen. 
Vaccination trials with a protein subunit vaccine including CNE are currently 
being performed in horses.  
 
Studies of fibronectin-binding proteins of Streptococcus equi (II) 
In this study, a novel Fn-binding protein of S. equi (FNEB) was described (Fig. 7). 
FNEB displays a signal sequence and a typical cell wall-anchoring domain with an 
LPxTG motif. FNEB can thus be predicted as cell surface-located, contrary to the 
two previously characterised fibronectin-binding proteins of S. equi FNE and SFS. 
Western ligand blots with two recombinant proteins, one corresponding to the 
mature protein (FNEB L) and one corresponding to the C-terminal half (FNEB S), 
confirmed that the binding activity is located near the C-terminus, and that it 
interacts specifically with the 29-kDa fragment of Fn. This part of the protein 
contains a number of characteristic Fn-binding repeats described in the section 
Bacterial binding to components of the extracellular matrix. This study also 
showed that the previously characterised proteins FNE and SFS both bind to the 
40-kDa collagen-binding fragment of Fn. Binding-inhibition studies with 
iodinated Fn added to microwells with immobilised FNEB, SFS and FNE showed 
a cross-inhibition between FNE and SFS, indicating that these proteins bind to 
overlapping, or nearby located sites on the Fn molecule. As expected, FNEB could 
not be used to inhibit the binding activity of FNE or SFS and vice versa.  
 
Streptococcus equi is known to bind Fn to a much lower degree than 
S. zooepidemicus (Lindmark et al., 1999). By measuring the binding of iodinated 
Fn-fragments to S. equi cells, it was shown that the observable binding is primarily 
directed to the 29-kDa domain. Furthermore, FNEB L could be used to inhibit the 
binding of both radiolabelled 29-kDa fragments and whole Fn to S. equi cells, 
indicating that FNEB is the primary adhesin that mediates binding of Fn to S. equi 
cells grown in vitro. As described previously, experiments with S. aureus  and 
S pyogenes mutants have revealed that a decreased binding to Fn is associated 
with an increase in invasiveness and virulence. Considering the comparatively low 
ability of S. equi to bind Fn compared with the evolutionary parental 
S. zooepidemicus, we postulate that this decreased adhesion is a contributing factor 
to its more virulent phenotype.    30
Based on the low, but observable binding to Fn, it could be predicted that FNEB is 
expressed under laboratory conditions, albeit at a low level. To test this 
hypothesis, total RNA was prepared from S. equi cells at the logarithmic phase of 
growth, followed by cDNA synthesis using RT-PCR with short random primers. 
The relative amounts of transcripts of fne, sfs, and fneB were measured by gene-
specific PCR, with the housekeeping gene gyrA used as a control. The highest 
expression was observed for gyrA (clear PCR-product after 22 cycles), followed 
by fne (24 cycles), fneB (27 cycles) and sfs (29 cycles). This pattern fits well with 
previous studies where transcripts of fne, but not sfs, were detected by Northern 
blots (Lindmark & Guss, 1999). As mentioned previously, native FNE has also 
been isolated from growth cultures (Lindmark et al., 2001), indicating a relatively 
high expression. Analyses of antibody titres from mice and horses with or without 
S. equi infections were used to assess the expression of FNEB during infection. A 
significant increase in antibody titres in mice with experimental infection and in 
convalescent horses indicates that FNEB is expressed during infection and 
exposed to the immune system.  
 
IdeE, an IgG-endopeptidase of S. equi subsp. equi (III) 
In all mammals, immunoglobulin G (IgG) has a key role in the defence against 
bacterial pathogens. By detecting antigens of the invading bacterium, the IgG 
molecule can mediate bacterial killing either by activating the classical 
complement system or by marking the bacterium for ingestion by phagocytes, an 
activity called opsonisation. Recognition by IgG can also inactivate bacterial 
toxins and adhesins. The IgG molecule is a glycoprotein made up of four subunits, 
two heavy chains and two light chains, linked by disulphide bridges. Its overall 
organisation is presented in Figure 8.  
 
Bacterial pathogens have evolved several different strategies to avoid recognition 
by IgG. One mechanism is to bind the Fc region (CH2-CH3) of the IgG molecule 
with specific surface receptors, such as the previously mentioned SeM and EAG 
proteins, and in that way block the interaction with Fc-receptors on phagocytes. 
Another strategy is to interfere with the interaction between IgG and the Fc-
receptors of phagocytes by releasing enzymes that either degrade the N-linked 
glycans of the IgG molecule, or cleave the peptide backbone of the IgG heavy 
chains (Collin & Olsen, 2003). IdeS, also known as Mac, is a secreted cysteine 
protease of S. pyogenes that cleaves the hinge region of human IgG with high 
specificity (Lei et al., 2002; von Pawel-Rammingen et al., 2002; von Pawel-
Rammingen & Bjorck, 2003). Genes for IdeS/Mac homologues have been found 
in the genomes of S. equi and S. zooepidemicus. In the present study, these genes 
were cloned and the proteins they encode, IdeE and IdeZ, were expressed and 
characterised.  
 
Purified horse IgG was incubated with recombinant IdeE and a cleavage product 
was visible when analysed by SDS-PAGE. The N-terminal end of the cleavage 
product was identified as GPSVFIFPP[K/N]PK by tandem mass spectrometry 
sequencing, confirming that IdeE and IdeS/Mac cleaves IgG at the same site. A   31
study of the proteolytic activity of recombinant IdeE and IdeZ on purified IgG 
from a selection of mammals shows that only antibodies containing the substrate 
site of IdeS/Mac are cleaved, indicating that the specificities of the two enzymes 
are very similar. Interestingly, horse IgG was cleaved less effectively than the IgG 
of e.g. dogs or humans. A likely explanation for this partial proteolysis would be 
that the hinge region of the dominating IgG isotype in horse serum (IgG4) is 
resistant to cleavage due to the lack of a distinct substrate site for IdeE/IdeZ. A 
Western blot with IgG4-specific antibodies confirmed that the heavy chain of this 
isotype was indeed intact after incubation with recombinant IdeE.  
 
Fig. 8. Schematic presentation of the IgG molecule. The N-terminal end of the heavy chains 
contain the variable, antigen-binding domain, VH (variable heavy), followed by three 
constant domains, CH1-CH3 (constant heavy 1-3). The heavy chains are connected in the 
hinge region by two disulphide bridges. The light chains contain a variable domain, VL 
(variable light) and a constant domain, CL (constant light), which is connected to the CH1 
domain by a single disulphide bridge. IdeE and IdeZ cleave the heavy chains at the same 
site as IdeS, in the hinge region on the C-terminal side of the disulphide bridges. 
 
The ability of S. equi and S. zooepidemicus to degrade antibodies was studied by 
determining the proteolysis of IgG in cell cultures. IgG-degradation was observed 
when S. equi was grown in the presence of horse serum, but not when grown with 
purified IgG (Fig. 9). In contrast, the growth of S. zooepidemicus in the presence 
of serum did not result in proteolysis of IgG. The fraction of S. equi-degraded IgG 
was cleaved at the same site as from the activity of IdeE. Together, these results 
suggest that the growth of S. equi in the presence of serum induces the expression 
of IdeE, but that no expression of IdeZ is induced when S. zooepidemicus is grown 
under the same conditions. Surprisingly, however, a Western blot confirmed that 
the IgG4 fraction in the horse serum had been completely cleaved by S. equi, 
indicating that the observed activity is due to the expression of an unknown 
enzyme rather than IdeE. Another possible explanation for this result could be that 
the native IdeE is not structurally and functionally equivalent to the recombinant   32
enzyme, or that an unknown factor produced by S. equi is necessary for its full 
proteolytic activity. 
 
 
Fig. 9. Medium with horse IgG (1 mg/mL) or 10% horse serum was incubated overnight. 
The supernatant was analysed by SDS-PAGE. * = Medium inoculated with S. equi. The 
IgG-degradation product is indicated (arrow). 
 
FNE belongs to novel a family of fibronectin-binding and 
collagen-binding proteins of Streptococcus equi (IV) 
The recent discovery that FNE binds both Fn and collagen and that no homologues 
of this protein have been identified in any related bacterial species led us to 
investigate whether any genes for putative paralogues to this protein could be 
found in the S. equi genome. Four ORFs encoding proteins with similarities to 
FNE and FNEB were found by a BLAST search in the publicly accessible genome 
at Sanger Center (http://www.sanger.ac.uk/Projects/Microbes/). Of these four 
novel proteins, FNEC, FNEE and FNEF have characteristic C-terminal cell wall- 
and membrane-spanning regions with putative sortase-substrate sites, and can thus 
be predicted as cell wall-anchored (Fig. 7). However, the gene encoding FNED is 
interrupted by a stop codon approximately halfway into the gene. As a result, the 
ORF encodes a truncated protein, and without a C-terminal cell wall sorting signal 
it is likely to be secreted in the growth medium in a similar way to FNE. The FNE-
like regions of these proteins are located in the N-terminal ends, and the C-
terminal parts are either not transcribed (FNED) or contain unrelated collagen-like 
repeats (FNEC, FNEF) or P/K-rich repeats (FNEE).  
 
To determine the binding activity of the FNE-like proteins, a microwell assay was 
used. Radiolabelled plasma Fn and collagen type I in PBS-T were added to wells 
coated with the same molar concentration of each recombinant protein and the 
specific binding was measured. FNEE was found to be the only protein of this 
family apart from FNE with binding activity to both Fn and collagen. However, 
the remaining three novel proteins (FNEC, FNED and FNEF) bound different 
amounts of soluble collagen. The FNEB S construct (Fig. 7) representing the N-
terminal part of FNEB was the only recombinant protein in the study with no   33
binding activity to either ligand. An alignment of the FNE-like regions showed 
patches of conserved residues among all proteins, and did not give any obvious 
clues to the observed differences in binding specificities or the location of the 
binding sites.   
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Future perspectives 
As shown in Lindmark et al (1999) and in II, a clear difference in the adhesive 
properties of S. equi and S. zooepidemicus is that the former binds considerably 
less Fn, and especially the 40-kDa fragment of Fn, when grown under standard 
laboratory conditions. In II, we postulated that this could be an important factor 
behind the invasive nature of S. equi infection. The finding that S. equi harbours at 
least two Fn-binding proteins that appear to be cell-wall anchored (FNEB and 
FNEE) merits further study of the expression of these proteins, and of the Fn-
binding activity of S. equi cells, under different growth conditions and growth 
phases. Expression and binding studies could, for example, be performed with 
cells grown in the presence of blood, under anaerobic conditions, in iron-depleted 
medium or – even better – with cells isolated from infected horses. Studies with 
S. pyogenes have shown that growth in plasma or blood increases the expression 
of several secreted and cell surface-bound proteins (Graham et al., 2005; 
Johansson et al., 2005), and our own cell culture experiments in III indicate that 
the presence of blood components also influences the expression of virulence 
factors in S. equi. In a study by Meehan et al. (1998), FnBP/SeM was identified as 
the major cell wall-associated protein of S. equi. However, this work, like most 
ligand-binding studies with S. equi, was performed with cells from overnight 
cultures grown in standard laboratory culture medium. A large number of novel 
S. equi proteins with cell wall-anchoring motifs have been characterised since 
then, and genes for many more can be found in the genome. Given this seemingly 
abundant arsenal of adhesins, it is likely that different cell surface proteins are 
expressed during different phases of infection – such as the initial attachment to 
the tonsils, the proliferation inside the lymph node and during the establishment of 
persistent infection in the guttural pouches.  
 
The Fn- and collagen-binding proteins FNE/FNZ have several putative paralogues 
in  S. equi and S. zooepidemicus, but no known homologues in other bacterial 
species. As we show in IV, the binding sites for Fn and collagen cannot easily be 
pinpointed by aligning the sequences of binders and non-binders within the FNE-
family of proteins. With truncated recombinants of FNE, FNEC, FNED, FNEE 
and FNEF, this could be elucidated. In addition, it would be interesting to search 
for homologues to these proteins in related streptococci, especially since recent 
studies have suggested that FNE could alter fluid homeostasis in infected tissues 
(Lidén et al., 2006 and unpublished results).  
 
The binding of Fn to the proteins SfbI and FnBPA of S. pyogenes and S. aureus 
has been shown to trigger integrin-mediated internalisation of these bacteria by 
epithelial and endothelial cells (Schwarz-Linek et al., 2004; Hauck & Ohlsen, 
2006). As we speculate in II, it is possible that FNEB serves a similar function in 
S. equi. It would therefore be interesting to evaluate wether FNEB contributes to 
the rapid internalisation of S. equi during the initial infection of the epithelium of 
the tonsil and adjacent lymphoid nodules (Timoney et al., 2006). 
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The cell culture experiments performed in III suggest that an unidentified IgG-
cleaving protease, rather than IdeE, is expressed when S. equi is grown in the 
presence of serum. An isogenic mutant lacking the ideE gene could be used to 
elucidate this. An alternative strategy would be to search the S. equi genome for 
genes encoding other extracellular proteases that could be expressed and 
characterised. 
 
In recent years, pili have been found on the surface of a number of streptococci 
including S. pyogenes, S. agalactiae and S. pneumoniae (Ton-That & Schneewind, 
2004; Mora et al., 2005; Dramsi et al., 2006; Marraffini et al., 2006). These 
proteinaceous filaments are assembled from proteins with LPxTG-type motifs by a 
specific sortase, and the genes for the building blocks and the sortase are often 
found within a single operon. Interestingly, the cne-gene in S. equi is located in the 
upstream end of a putative operon with two other genes; just downstream is a gene 
for a protein with (weak) similarities to several fimbrial subunit proteins in 
different Gram-positive bacteria, followed by a gene for a sortase-like protein. It 
can thus be postulated that CNE is incorporated to the end of a pilus structure with 
the putative fimbrial subunit proteins as the main building block (which would 
explain the lack of a typical cell wall-spanning region in CNE). The best way to 
test this hypothesis would probably be with electron microscopy, using cells 
coated with gold particles conjugated to antibodies recognising CNE and/or the 
putative fimbrial subunit protein.  
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